Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Saint Quentin – page 3

34 clinical trials in Saint Quentin, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Saint Quentin at a glance
34
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

34 trials in Saint Quentin

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Brigatinib
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bms-986315
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Saint Quentin

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on Multiple Myeloma treatments, including innovative combination therapies and maintenance approaches. Studies evaluate novel treatments like elranatamab and daratumumab for both newly diagnosed and relapsed cases.

  • Treatment optimization for various disease stages
  • Novel drug combinations
  • Maintenance therapy strategies

Additional trials explore treatments for Polycythemia Vera and other hematologic conditions.

02 Lung Cancer Research

Extensive studies on Non-Small Cell Lung Cancer investigating immunotherapy combinations and targeted treatments. Research includes trials for both early-stage and metastatic disease, with particular focus on specific genetic mutations.

  • Immunotherapy combinations
  • Targeted therapies for specific mutations
  • Novel treatment approaches for advanced disease

Includes studies on ALK-positive and BRAF-mutant variants.

03 Gastrointestinal Oncology

Innovative research in colorectal cancer treatment, particularly focusing on minimal residual disease detection and personalized treatment approaches using circulating tumor DNA analysis.

  • Biomarker-driven treatment decisions
  • Post-surgical therapy optimization
  • Advanced stage disease management

Studies aim to improve patient outcomes through precise treatment selection.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.